| Lastest Insider Transactions Of ACADIA PHARMACEUTICALS INC ( ACAD ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2025-03-24 | Sell | 1,095 | 17.05 | 18,670 | 2025-03-26 20:10:01 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2025-03-24 | Option Exercise | 2,142 | 0.00 | 0 | 2025-03-26 20:10:01 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2025-03-24 | Sell | 3,171 | 17.05 | 54,066 | 2025-03-26 20:06:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2025-03-24 | Option Exercise | 6,178 | 0.00 | 0 | 2025-03-26 20:06:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Directior | 2025-03-05 | Sell | 4,919 | 18.23 | 89,673 | 2025-03-06 18:30:15 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2025-02-23 | Sell | 475 | 19.96 | 9,481 | 2025-02-25 18:48:49 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2025-02-23 | Option Exercise | 840 | 0.00 | 0 | 2025-02-25 18:48:49 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2025-02-23 | Sell | 773 | 19.96 | 15,429 | 2025-02-25 18:46:58 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2025-02-23 | Option Exercise | 1,353 | 0.00 | 0 | 2025-02-25 18:46:58 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Sell | 10,329 | 16.81 | 173,630 | 2024-11-19 20:43:42 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Option Exercise | 19,826 | 0.00 | 0 | 2024-11-19 20:43:42 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Sell | 4,073 | 16.81 | 68,467 | 2024-11-19 20:41:52 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Option Exercise | 7,930 | 0.00 | 0 | 2024-11-19 20:41:52 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Sell | 10,259 | 16.81 | 172,454 | 2024-11-19 20:40:08 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Option Exercise | 19,826 | 0.00 | 0 | 2024-11-19 20:40:08 |
| ACAD | ACADIA PHARMACEUTICALS INC | Ndu Adora | Directior | 2024-10-12 | Option Exercise | 4,381 | 0.00 | 0 | 2024-10-15 18:05:05 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-08-16 | Sell | 9,733 | 15.28 | 148,720 | 2024-08-20 18:46:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-08-16 | Sell | 9,534 | 15.28 | 145,680 | 2024-08-20 18:43:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-08-16 | Sell | 31,747 | 15.28 | 485,094 | 2024-08-20 18:40:42 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-06-08 | Sell | 975 | 14.79 | 14,420 | 2024-06-11 18:00:05 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-06-08 | Option Exercise | 1,893 | 0.00 | 0 | 2024-06-11 18:00:05 |
| ACAD | ACADIA PHARMACEUTICALS INC | Ndu Adora | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:21 |
| ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:16 |
| ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:13 |
| ACAD | ACADIA PHARMACEUTICALS INC | SOLAND DANIEL B | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Directior | 2024-05-29 | Option Exercise | 6,652 | 0.00 | 0 | 2024-05-31 18:00:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-05-01 | Sell | 3,503 | 16.94 | 59,341 | 2024-05-03 18:00:51 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-05-01 | Option Exercise | 6,814 | 0.00 | 0 | 2024-05-03 18:00:51 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-05-01 | Sell | 3,477 | 16.94 | 58,900 | 2024-05-03 18:00:48 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-05-01 | Option Exercise | 6,814 | 0.00 | 0 | 2024-05-03 18:00:48 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-05-01 | Sell | 1,326 | 16.94 | 22,462 | 2024-05-03 18:00:40 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-05-01 | Option Exercise | 2,596 | 0.00 | 0 | 2024-05-03 18:00:40 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-05-01 | Sell | 11,427 | 16.94 | 193,573 | 2024-05-03 18:00:28 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-05-01 | Option Exercise | 22,391 | 0.00 | 0 | 2024-05-03 18:00:28 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-04-05 | Sell | 26,574 | 17.87 | 474,877 | 2024-04-09 18:00:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-04-05 | Option Exercise | 51,999 | 0.00 | 0 | 2024-04-09 18:00:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-04-05 | Sell | 2,568 | 17.87 | 45,890 | 2024-04-09 18:00:13 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-04-05 | Option Exercise | 5,024 | 0.00 | 0 | 2024-04-09 18:00:13 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Sell | 1,790 | 17.87 | 31,987 | 2024-04-09 18:00:12 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Option Exercise | 3,499 | 0.00 | 0 | 2024-04-09 18:00:12 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Sell | 1,790 | 17.87 | 31,987 | 2024-04-09 18:00:12 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-04-05 | Option Exercise | 3,499 | 0.00 | 0 | 2024-04-09 18:00:12 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-04-05 | Sell | 2,716 | 17.87 | 48,535 | 2024-04-09 18:00:06 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-04-05 | Option Exercise | 5,275 | 0.00 | 0 | 2024-04-09 18:00:06 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-03-25 | Sell | 5,140 | 17.90 | 92,006 | 2024-03-27 20:00:16 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-03-25 | Sell | 17,714 | 17.90 | 317,081 | 2024-03-27 19:58:15 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-03-25 | Sell | 5,434 | 17.90 | 97,269 | 2024-03-27 19:57:03 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-02-23 | Sell | 772 | 24.67 | 19,045 | 2024-02-27 18:13:45 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2024-02-23 | Option Exercise | 1,353 | 0.00 | 0 | 2024-02-27 18:13:45 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-02-23 | Sell | 624 | 24.67 | 15,394 | 2024-02-27 18:10:33 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 2024-02-23 | Option Exercise | 1,107 | 0.00 | 0 | 2024-02-27 18:10:33 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-02-23 | Sell | 474 | 24.67 | 11,694 | 2024-02-27 18:07:09 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 2024-02-23 | Option Exercise | 840 | 0.00 | 0 | 2024-02-27 18:07:09 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-02-23 | Sell | 5,577 | 24.67 | 137,585 | 2024-02-27 18:02:20 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-02-23 | Option Exercise | 10,946 | 0.00 | 0 | 2024-02-27 18:02:20 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-01-06 | Sell | 3,732 | 29.96 | 111,811 | 2024-01-09 18:00:35 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2024-01-06 | Option Exercise | 9,528 | 0.00 | 0 | 2024-01-09 18:00:35 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2024-01-06 | Sell | 731 | 29.96 | 21,901 | 2024-01-09 18:00:33 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2024-01-06 | Option Exercise | 1,287 | 0.00 | 0 | 2024-01-09 18:00:33 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2024-01-06 | Sell | 590 | 29.96 | 17,676 | 2024-01-09 18:00:29 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2024-01-06 | Option Exercise | 1,634 | 0.00 | 0 | 2024-01-09 18:00:29 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-12-15 | Sell | 2,000 | 28.30 | 56,600 | 2023-12-15 19:37:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-11-17 | Sell | 4,960 | 22.64 | 112,294 | 2023-11-21 18:00:22 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-11-17 | Option Exercise | 9,912 | 0.00 | 0 | 2023-11-21 18:00:22 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-11-17 | Sell | 5,108 | 22.64 | 115,645 | 2023-11-21 18:00:21 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-11-17 | Option Exercise | 9,912 | 0.00 | 0 | 2023-11-21 18:00:21 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-11-17 | Sell | 1,985 | 22.64 | 44,940 | 2023-11-21 18:00:14 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-11-17 | Option Exercise | 3,964 | 0.00 | 0 | 2023-11-21 18:00:14 |
| ACAD | ACADIA PHARMACEUTICALS INC | Ndu Adora | Directior | 2023-10-12 | Option Exercise | 4,381 | 0.00 | 0 | 2023-10-16 17:30:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-10-05 | Sell | 16,369 | 21.96 | 359,463 | 2023-10-06 22:00:00 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-10-05 | Option Exercise | 36,174 | 0.00 | 0 | 2023-10-06 22:00:00 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-10-05 | Sell | 51,563 | 21.96 | 1,132,324 | 2023-10-06 21:59:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-10-05 | Option Exercise | 103,999 | 0.00 | 0 | 2023-10-06 21:59:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-09-15 | Sell | 2,000 | 25.88 | 51,760 | 2023-09-19 18:31:39 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-08-21 | Sell | 10,000 | 29.00 | 289,970 | 2023-08-23 19:31:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-07-14 | Sell | 100,000 | 30.04 | 3,004,350 | 2023-07-18 18:00:06 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-07-14 | Option Exercise | 100,000 | 20.77 | 2,077,000 | 2023-07-18 18:00:06 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-07-11 | Sell | 71,602 | 25.04 | 1,792,899 | 2023-07-13 20:27:47 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-06-15 | Sell | 2,000 | 24.15 | 48,300 | 2023-06-16 16:38:53 |
| ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Directior | 2023-06-12 | Sell | 4,500 | 24.87 | 111,906 | 2023-06-14 17:14:46 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-06-08 | Sell | 974 | 25.02 | 24,369 | 2023-06-12 20:48:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-06-08 | Option Exercise | 1,893 | 0.00 | 0 | 2023-06-12 20:48:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | SOLAND DANIEL B | Directior | 2021-06-22 | Option Exercise | 18,002 | 0.00 | 0 | 2023-06-05 21:46:39 |
| ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Directior | 2021-06-22 | Option Exercise | 18,002 | 0.00 | 0 | 2023-06-05 21:42:26 |
| ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Directior | 2021-06-22 | Option Exercise | 18,002 | 0.00 | 0 | 2023-06-05 21:39:43 |
| ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Directior | 2021-06-22 | Option Exercise | 18,002 | 0.00 | 0 | 2023-06-05 21:38:09 |
| ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Directior | 2022-06-07 | Option Exercise | 16,862 | 0.00 | 0 | 2023-06-05 21:34:45 |
| ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2023-05-22 | Buy | 896,522 | 25.33 | 22,707,098 | 2023-05-24 17:09:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2023-05-22 | Option Exercise | 25,000 | 17.01 | 425,250 | 2023-05-24 17:09:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2023-05-22 | Buy | 896,522 | 25.33 | 22,707,098 | 2023-05-24 17:09:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2023-05-22 | Option Exercise | 25,000 | 17.01 | 425,250 | 2023-05-24 17:09:23 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-05-17 | Sell | 5,947 | 22.50 | 133,808 | 2023-05-19 18:54:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-05-17 | Option Exercise | 11,894 | 0.00 | 0 | 2023-05-19 18:54:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-05-17 | Sell | 15,310 | 22.50 | 344,475 | 2023-05-19 18:48:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-05-17 | Option Exercise | 29,738 | 0.00 | 0 | 2023-05-19 18:48:18 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-05-17 | Sell | 14,869 | 22.50 | 334,553 | 2023-05-19 18:43:20 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-05-17 | Option Exercise | 29,738 | 0.00 | 0 | 2023-05-19 18:43:20 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-04-29 | Sell | 917 | 21.18 | 19,422 | 2023-05-02 19:06:34 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-04-29 | Option Exercise | 3,005 | 0.00 | 0 | 2023-05-02 19:06:34 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-04-29 | Sell | 548 | 21.18 | 11,607 | 2023-05-02 19:04:58 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-04-29 | Option Exercise | 1,567 | 0.00 | 0 | 2023-05-02 19:04:58 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-04-29 | Sell | 7,806 | 21.18 | 165,331 | 2023-05-02 19:02:53 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-04-29 | Option Exercise | 15,625 | 0.00 | 0 | 2023-05-02 19:02:53 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-04-07 | Sell | 523 | 18.14 | 9,487 | 2023-04-11 21:15:57 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-04-07 | Option Exercise | 1,489 | 0.00 | 0 | 2023-04-11 21:15:57 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-04-05 | Sell | 1,751 | 18.16 | 31,798 | 2023-04-07 20:44:46 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-04-05 | Option Exercise | 5,024 | 0.00 | 0 | 2023-04-07 20:44:46 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-04-05 | Sell | 701 | 18.16 | 12,730 | 2023-04-07 20:41:27 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-04-05 | Option Exercise | 2,009 | 0.00 | 0 | 2023-04-07 20:41:27 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-04-05 | Sell | 1,916 | 18.16 | 34,795 | 2023-04-07 20:37:32 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-04-05 | Option Exercise | 5,275 | 0.00 | 0 | 2023-04-07 20:37:32 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-04-05 | Sell | 8,582 | 18.16 | 155,849 | 2023-04-07 20:34:55 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-04-05 | Option Exercise | 17,333 | 0.00 | 0 | 2023-04-07 20:34:55 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-04-05 | Sell | 1,456 | 18.16 | 26,441 | 2023-04-07 20:32:09 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-04-05 | Option Exercise | 4,773 | 0.00 | 0 | 2023-04-07 20:32:09 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-02-23 | Sell | 350 | 18.78 | 6,573 | 2023-02-27 21:00:44 |
| ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Officer | 2023-02-23 | Option Exercise | 840 | 0.00 | 0 | 2023-02-27 21:00:44 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-02-23 | Sell | 577 | 18.78 | 10,836 | 2023-02-27 21:00:34 |
| ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, Chief Financial Officer | 2023-02-23 | Option Exercise | 1,353 | 0.00 | 0 | 2023-02-27 21:00:34 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-02-23 | Sell | 3,851 | 18.78 | 72,322 | 2023-02-27 21:00:28 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-02-23 | Option Exercise | 10,945 | 0.00 | 0 | 2023-02-27 21:00:28 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-02-23 | Sell | 803 | 18.78 | 15,080 | 2023-02-27 21:00:26 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-02-23 | Option Exercise | 2,214 | 0.00 | 0 | 2023-02-27 21:00:26 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-02-23 | Sell | 461 | 18.78 | 8,658 | 2023-02-27 21:00:17 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-02-23 | Option Exercise | 1,107 | 0.00 | 0 | 2023-02-27 21:00:17 |
| ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Directior | 2023-01-12 | Sell | 12,500 | 18.25 | 228,125 | 2023-01-17 17:17:32 |
| ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Directior | 2023-01-12 | Option Exercise | 12,500 | 17.01 | 212,625 | 2023-01-17 17:17:32 |
| ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2023-01-12 | Option Exercise | 30,000 | 5.22 | 156,600 | 2023-01-17 16:22:57 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-01-06 | Sell | 3,904 | 17.13 | 66,877 | 2023-01-10 20:38:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 2023-01-06 | Option Exercise | 9,528 | 0.00 | 0 | 2023-01-10 20:38:07 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-01-06 | Sell | 532 | 17.13 | 9,113 | 2023-01-10 20:30:16 |
| ACAD | ACADIA PHARMACEUTICALS INC | Teehan Brendan | EVP, COO, Head of Commercial | 2023-01-06 | Option Exercise | 1,286 | 0.00 | 0 | 2023-01-10 20:30:16 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-01-06 | Sell | 589 | 17.13 | 10,090 | 2023-01-10 20:20:10 |
| ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 2023-01-06 | Option Exercise | 1,633 | 0.00 | 0 | 2023-01-10 20:20:10 |
